Patent Assignment
Reel/Frame 021018/0510
Corrective Assignment to Correct the U.S. Patent No. 6,686,179 Was Erroneously Typed as U.S. Patent No. 6,684,179 Previously Recorded on Reel 017921 Frame 0492. Assignor(S) Hereby Confirms the Change of Name.
Recorded: 2008-05-30
Pages: 12
Assignor
AVENTIS BEHRING L.L.C.
Executed: 2003-11-27
Assignee
DELTA BIOTECHNOLOGY LIMITED
CASTLE COURT, 59 CASTLE BOULEVARD, NOTTINGHAM, NG7 1FD, UNITED KINGDOM
Covered Property
(1)
Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Contract
Mar 1, 2002
From: RHONE-POULENC RORER S.A.
To: CENTEON L.L.C.
Reel/Frame 012653/0458 →
Change of Name
Mar 11, 2002
From: CENTEON L.L.C.
To: AVENTIS BEHRING L.L.C.
Reel/Frame 012698/0406 →
Assignment of Assignor's Interest
Jul 11, 2006
From: AVENTIS BEHRING L.L.C.
To: DELTA BIOTECHNOLOGY LTD.
Reel/Frame 017921/0492 →
Change of Name
Dec 31, 2007
From: DELTA BIOTECHNOLOGY LIMITED
To: NOVOZYMES DELTA LIMITED
Reel/Frame 020299/0814 →
Change of Name
Dec 31, 2007
From: NOVOZYMES DELTA LIMITED
To: NOVOZYMES BIOPHARMA UK LIMITED
Reel/Frame 020299/0491 →
Corrective Assignment to Correct the U.S. Patent No. 6,686,179 Was Erroneously Typed as U.S. Patent No. 6,684,179 Previously Recorded on Reel 020299 Frame 0491. Assignor(S) Hereby Confirms the Change of Name.
May 30, 2008
From: NOVOZYMES DELTA LIMITED
To: NOVOZYMES BIOPHARMA UK LIMITED
Reel/Frame 021018/0539 →
Corrective Assignment to Correct the U.S. Patent No. 6,686,179 Was Erroneously Typed as U.S. Patent No. 6,684,179 Previously Recorded on Reel 020299 Frame 0814. Assignor(S) Hereby Confirms the Change of Name.
May 30, 2008
From: DELTA BIOTECHNOLOGY LIMITED
To: NOVOZYMES DELTA LIMITED
Reel/Frame 021018/0534 →
Assignment of Assignor's Interest
Oct 7, 2010
From: NOVOZYMES BIOPHARMA UK LIMITED
To: NOVOZYMES BIOPHARMA DK A/S
Reel/Frame 025105/0517 →